Angiotensin II (All) in adrenal glomerulosa cells activates phospholipase C resulting in the formation of inositol phosphates and diacylglycerol rich in arachidonic acid (AA). Although glomerulosa cells can metabolize AA via cyclooxygenase (CO), this pathway plays little role in aldosterone synthesis. Recent evidence suggests that the lipoxygenase (LO) pathway may be important for hormonal secretion in endocrine tissues such as the islet of Langerhans. However, the capacity of the glomerulosa cell to synthesize LO products and their role in aldosterone secretion is not known. To study this, the effect of nonselective and selective LO inhibitors on All, ACTH, and potassium-induced aldosterone secretion and LO product formation was evaluated in isolated rat glomerulosa cells. BW755c, a nonselective LO inhibitor dose dependently reduced the AII-stimulated level of aldosterone without altering All binding (91±6 to 36±4 ng/106 cells/h 10-' M, P < 0.001). The same effect was observed with another nonselective LO blocker, phenidone, and a more selective 12-LO inhibitor, Baicalein. In contrast U-60257, a selective 5-LO inhibitor did not change the All-stimulated levels of aldosterone (208±11% control, All 10-9 M vs. 222±38%, All + U-60257). The LO blockers action was specific for All since neither BW755c nor phenidone altered ACTH or K+-induced aldosterone secretion. All stimulated the formation of the 12-LO product 12-hydroxyeicosatetraenoic acid as measured by ultraviolet detection and HPLC in AA loaded cells and by a specific RIA in unlabeled cells (501±50 to 990±10 pg/105 cells, P < 0.02). BW755c prevented the Allmediated rise in 12-HETE formation. In contrast, neither ACTH nor K+ increased 12-HETE levels. The addition of 12-HETE or its unstable precursor 12-HPETE (10-9 or 10' M) completely restored All action during LO blockade. All also produced an increase in 15-HETE formation, but the 15-LO products had no effect on aldosterone secretion. These studies suggest that the 12-LO pathway plays a key role as a new specific mediator of All-induced aldosterone secretion.
Introduction
Angiotensin II (AII),' potassium (K+), and ACTH are the major stimulators of aldosterone synthesis in vitro and in man (1) (2) (3) All three agonists activate the calcium messenger system, however, only All induces the hydrolysis of phosphoinositides and releases intracellular calcium (4) (5) (6) . After binding to its receptor, All activates phospholipase C, which induces the formation of diacylglycerol and the release of arachidonic acid (AA) (7) . The adrenal glomerulosa cell has been shown to metabolize AA via the cyclooxygenase (CO) pathway to prostaglandins E2 and I2 (8) (9) (10) . However, considerable evidence suggests that the CO pathway is not involved in basal or Allmediated aldosterone production (10) (11) .
Recent studies in rat pancreatic islets have shown that the lipoxygenase (LO) products of AA, such as 12 hydroperoxyeicosatetraenoic acid are important mediators of glucose-induced insulin secretion (12, 13) . However, the capacity of the adrenal glomerulosa cell to synthesize LO products and their role in aldosterone synthesis is not known. We have evaluated the effect of All, K+, and ACTH on LO product formation in isolated rat adrenal glomerulosa cells. In addition, we have studied the functional role of LO pathway activation with the use of selective CO and LO inhibitors. The results suggest that the 12-LO pathway plays a key role in mediating AII-induced aldosterone synthesis.
Methods
Preparation of isolated rat adrenal glomerulosa cells. The cells were freshly prepared using the method of Williams et al. (14) . Male Sprague-Dawley rats (200-225 g) were decapitated and the adrenals removed and trimmed of fat and placed in normal saline. Capsules were separated by gross dissection and incubated with collagenase (3.7 mg/ml) and deoxyribonuclease (0.05 mg/ml) in a modified KrebsRinger bicarbonate buffer (KRBG) containing 4% bovine serum albumin (BSA, Pentex Fraction V, fatty acid free) essential and nonessential amino acids, L-glutamine and glucose for 50 min in a Dubnoff metabolic shaker under 95% 02, 5% CO2. The cells were then mechanically separated by gentle pipetting and filtered through a gauze mesh. The suspension was spun at 100 g and washed three times with the KRBG and the glomerulosa cells were resuspended in the same buffer solution (K+ 3.7 meq/liter) to yield 150,000 cells per 2 ml.
The viability of the cells was 95% as determined using trypan blue exclusion.
Incubation ofrat glomerulosa cells. The cell suspension in 2 ml of KRBG buffer with 4% BSA was incubated in the presence or absence of the various test compounds in a metabolic shaker for 60 min at 37°C under a 95% 02/5% CO2 atmosphere. The cells were incubated with graded doses of All, ACTH, or K+ (2 X 10-" to 2 X 10-8 M, 1 X 10-" to 1 X 10-8 M, and 3.7 to 10.7 meq/liter, respectively) either alone or with various AA inhibitors. The inhibitors used were:
BW755c (3 amino-m-trifluoromethyl-phenyl-2-pyrazoline 10-7, -I0-' M, Burroughs Wellcome Co., Beckenham, Kent, UK) or phenidone (I0-' M, Sigma) both nonselective LO inhibitors, baicalein (1o6 M BioMol Research Laboratories, Philadelphia, PA) a more selective 12 LO inhibitor (15) , meclofenamate (10-3 M, Sigma Chemical Co., poxygenase; LTB4, leukotriene B4; NDGA, nordihydroguaniaretic acid; 12-HPETE, 12 hydroperoxyeicosatetraenoic acid.
St. Louis, MO), a specific CO inhibitor, and U60, 257 (16) 10-6 M (Piriprost, Dr. Michael Bach, UpJohn Co., Kalamazoo, MI) a highly specific 5-LO inhibitor. To evaluate whether 12-HETE formation is via a cytochrome P450 epoxygenase enzyme we also used two structurally distinct cytochrome P450 inhibitors, metyrapone and SKF 525A (2-diethylaminoethyl-2, 2-diphenylvalerate hycrochloride;
SmithKline & French, Philadelphia, PA) at 6 X l0-5 M concentration.
To study the functional effects of 12-LO products on basal aldosterone synthesis, the unstable product 12-HPETE (10-10 to 10-7 M, BioMol Research Laboratories) or the more stable 12 hydroxyeicosatetraenoic acid (12-HETE 10`0 to 10-8 M), was added directly or with All and BW755c to the cell suspension. Similarly, the 1 5-LO products 1 5-HPETE and 1 5-HETE were also studied for their effects on aldosterone secretion.
The HPLC purified HPETEs and HETEs were added in 0.01% ethanol. Similar amounts of ethanol concentrations were added to the control incubations.
To test the capacity of rat adrenal cells to convert exogenous AA to HETEs in the basal state and after All stimulation, highly purified AA (1 MM, 99% pure, Nu Chek Prep Co., Elysian, MN) was preincubated with glomerulosa cell suspensions in 2 ml of BSA free KRBG buffer for 30 min. After this incubation step, the cells were washed twice with KRBG containing 4% BSA (fatty acid free, Pentex fraction V; Miles Laboratories, Naperville, IL) to remove all nonesterified AA. The incubations were then carried out as previously described for 60 min with no added agonist, All alone (l0-9 M) or All plus BW755c (10-4 M). An incubation of control medium with boiled cells was also performed to evaluate nonenzymatic oxidation of AA. At the end of the incubation period the reaction was stopped by adding 2 ml of 100% ethanol.
l2I-Angiotensin II binding. 1251-AII binding assays were performed as previously described (17) with minor modifications. Freshly obtained adrenal capsules from seven to eight rats per assay were homogenized with a Teflon glass homogenizer in a buffer containing 0.25 M sucrose, 1 mM EDTA and 10 mM Tris (pH 7.4, 4°C). The homogenate was centrifuged at 1500 g for 10 min. The supernate was then spun at 20,000 for 30 min and the pellet washed twice in the incubatiop buffer containing 120 mM NaCI, 1 mM EDTA, 5 mM dithiothreitol, 2 mM MgCl2, 0.2% BSA, and 50 mM Tris (pH 7.4). The pellet was then resuspended in the incubation buffer to yield a protein concentration of 240-300 Ag/ml. '251-AII (New England Nuclear, Boston, MA; specific activity 1,880 gCi/Mg) 150,000 dpm was incubated in triplicate with various concentrations ofunlabeled All (3 X l0-1o-10-6 M). For each concentration triplicate tubes in a final volume of 0.5 ml were incubated for 45 min at 22°C. Bound and free ligand were separated by Milipore filtration using buffer presoaked glass fiber GF/C filters (Whatman Inc., Clifton, NJ). Filters were counted in a gamma counter (Gamma 4000; Beckman Instruments, Inc., Fullerton, CA). Nonspecific binding defined as filter bound labeled ligand in the presence of 10-6 M unlabeled All was 6±1% of the total binding. Protein concentration was determined by method of Lowry.
Measurement ofHETEs
Extraction. After precipitation of cell proteins in 100% ethanol and removal of buffer and solvent under nitrogen, the sample was redissolved in 15% ethanol and water, acidified to pH 4.0 with hydrochloric acid (1 N) and transferred to a octadecasilyl C18 mini column (SEP-PAK, Waters Associates, Milford MA) that has been prewashed successively in 20 ml methanol and 20 ml water. The elution of HETEs was done using a modification of the method of Powell (18) . The column was successively washed with 15% ethanol and water (20 ml) , water (20 ml) , petroleum ether (6 ml) and the compounds of interest eluted with ethyl acetate (15 ml HPLC. The extracted sample in ethyl acetate was dried under nitrogen and redissolved in 100 Ml of 100% methanol. This sample was then injected into a series 4 HPLC (Perkin-Elmer Co., Norwalk, CT) equipped with a C18 column (Perkin-Elmer 3 micron, 10 cm length) and a LC-85 UV detector. The solvent mixture is a combination of an isocratic and gradient elution program modified from the method of Peters et al. (19) ; solvent A (0.01% acetic acid, pH 3.7), solvent B (acetonitrile), and solvent C (methanol). The initial solvent mixture was isocratic in 67% solvent A and 33% solvent B at 1 ml/min for 6 min. A convex gradient over 8 min then went to 10% A, 80% B, 10% C. At 14 min a wash with 100% B began and continued for 4 min. The system was then regenerated to the initial solvent ratio with a linear gradient over 4 min. With this technique any prostaglandins (PGs) and leukotrienes in the sample are eluted before 5 min. The HETEs or HPETEs elute between 10 and 12 min, while unreacted AA elutes at 14.0 min. The sensitivity ofthis system for detection ofthe HETEs is I ng at 235 nM. The recovery of added 3H 5-, 12-or 15-HETE (New England Nuclear) taken through the entire process ofdeproteinization, extraction, and HPLC with collection of the appropriate fraction in a Frac 100 fraction collector (Pharmacia Fine Chemicals, Uppsala Sweden) is 74±2% (SE, n = 20).
To confirm the presence of 12-HETE and to better separate 12-HETE from other LO products we also used a reverse phase HPLC system with a Shandon 25 CM high resolution 3-micron column (Keystone Scientific, State College, PA) using a gradient elution program with solvent A (0.0 1% acetic acid, ph 3.7), solvent B (acetonitrite), and solvent C (methanol). The initial solvent mixture is 33% A, 10% B, 57% C which then went to 10% A, 10% B, and 80% C over 20 min. Then at 20 min a wash begins with 10% B and 90% C for 5 min. In this system the sensitivity for 12-HETE is 1 ng at 235 nM. 12-HETE elutes at 16.8 min, whereas 15-HETE elutes at 15.2 min.
Radioimmunoassay of 12 and 15-HETE. Since cells produce too little endogenous HETE to be reliably seen by UV detection, a specific RIA technique was used to quantify endogenous 12-HETE formed in the basal state and after agonist stimulation. We used the specific antisera provided by Advanced Magnetics, Inc. (Boston, MA) in a working titer of 2 X I03 dilution giving a B. of 54%. The cross-reactivity of this antiserum is: 12(S)-HETE 100%, 12(R)-HETE < 0.01%, 1 5-HETE 0.3%, 5 HETE 0.2%, thromboxane B2 (TXB2) < 0.1%, PGE2 0.1%, 6 keto prostacycline la (PGFla) 0.1%, leukotriene B4 (LTB4) 0.1 %, arachidonic acid 0.1%, 8,15 and 5,15 diHETE 0.1 % and 8,9, and 1 1-HETE; all < 0.01%. For the assay 100 gl of the appropriate dried fraction was incubated with antibody (100 Mul) and authentic [3H] 12-HETE tracer (4,000 cpm, New England Nuclear) in a phosphate buffer solution, pH 8.5 overnight at 4°C. Separation of bound from free was achieved by the addition of 700 ,ul ofdextran-coated charcoal. Nonspecific binding is < 6% with an assay blank of 8 pg/ml. The sensitivity of the method is 10 pg/ml with an intraassay variation of 8%. All control and experimental samples were run in the same assay. Validation procedures included the assay of known added amounts of standard and variable amounts of extract (r = 0.95). In addition, sample values gave an excellent correlation (r = 0.91; P < 0.01) when assayed using the well characterized independent 12-HETE antisera kindly provided by Dr. L. Levine, Brandeis University (20) . All samples for the RIA were stored in the dark under nitrogen at -70°C until assay. 1 
Results
Effect of LO inhibition on aldosterone synthesis. The nonselective LO inhibitor, BW755c (10-4 M) markedly reduced the AII-stimulated secretion of aldosterone (Fig. 1 a) . BW755c decreased the overall mean maximal All stimulated aldosterone secretion from 91±6 to 36±4 ng/106 cell per h (n = 12, P < 0.001). Similarly BW755c reduced All-mediated secretion of corticosterone (4.6±0.06 to 2.8±0.4 gg/106 cells per h, n = 3, P < 0.002) while the secretion rate was not significantly different than baseline (2.6±0.02 gg/106 cells). The inhibitory effect was dose dependent with significant reduction of AII-induced aldosterone synthesis by concentrations of BW755c starting at l0-7 M (Fig. 1 b) . In several experiments (7/12) BW755c at 10-4 M also reduced basal aldosterone secretion (42±5 to 30±3 ng/106 cells per h, n = 7, P < 0.01). In contrast, BW755c did not alter the sensitivity or peak secretion rate of aldosterone incubated with graded doses of ACTH (Fig. 2) or K+ (Fig. 3) . Another LO inhibitor, phenidone (l0-4 M) significantly reduced AII-stimulated aldosterone secretion (29±1 basal to 67±2 All 10-9 M vs. 50±2 ng/106 cells/hour All + phenidone n = 6, P < 0.05 vs. All alone). However, pheni- meq, n = 6, P = NS for K' alone vs. K' + phenidone, respectively). Since BW755c can also block the CO pathway, a selective CO blocker meclofenamate was studied to determine whether the effects of BW755c were due to CO inhibition. However, as shown in Table I , even a high concentration of meclofenamate (l0-3 M) did not prevent All-induced aldosterone synthesis. Baicalein, a more selective 12-LO inhibitor with little CO inhibitory effects was also studied. This more specific agent also reduced AII-mediated aldosterone secretion (10±0.5 basal vs. 32±2 ng/106 cells per h AllI 0-9 M vs. 20±2 All + baicalein 10-6 M, n = 6, P < 0.02 All vs. All + baicalein). The steroidogenic inhibitory actions were also associated with a reduction in 12-HETE formation (120±2% control All vs. 78±5% All + baicalein, P < 0.01).
To examine the role of the 5-LO pathway in All action, a selective 5-LO inhibitor U60, 257 was studied. As shown in Table I , this highly selective 5-LO inhibitor did not attenuate All stimulatory effects on aldosterone synthesis, suggesting that BW755c, phenidone, and baicalein are not acting via 5-LO inhibition to block All effects.
Effect ofLO inhibition on l2I-AII binding to glamerulosa membranes. Since LO inhibition selectively blocked All mediated aldosterone synthesis, the effect of the LO inhibitor BW755c on All binding to glomerulosa cell membranes was studied. Mean All receptor concentration was similar in control membranes and in those co-incubated with BW755c, respectively, [ Effect of AII, ACTH, and K' on HETE formation. All (10-9 M) stimulated the formation of immunoreactive 12-HETE (Fig. 4 ) (501±50 to 990±10 pg/105 cells P < 0.02). In addition, BW755c reduced the stimulated level back to the control level (Fig. 4) . All also slightly stimulated immunoreactive 15-HETE levels (756±80 to 1,050±90 pg/105 cells, n = 4, P < 0.05). Similarly, in cells prelabeled with 99% pure AA, All stimulated predominately 1 2-HETE as revealed by ultraviolet detection at 235 nM in a sensitive reverse-phase HPLC system (Fig. 5, a-c) (Table II) .
To evaluate whether 12-HETE formation is via a cytochrome P450 epoxygenase enzyme, the effect of metyrapone and SKF525A on 12-HETE formation was studied. At 5 X 10-5 M concentration metyrapone and SKF525A similarly reduced aldosterone secretion (1.4±3 to 0.4±0.1 and 0.46±0.1 ng/106 cells per h, respectively, n = 4, P < 0.01). However, neither inhibitor altered 12-HETE levels (517±41 basal vs. 651±37 vs. 739±89 pg/105 cells, respectively, n = 4, P> 0.1).
Effect of 12 and 15 LO products on aldosterone secretion. To further evaluate the functional role of the 12-LO pathway for All action, the effect of 12-HETE and its unstable precursor 12-HPETE on restoring All stimulation of aldosterone during BW755c treatment was studied. 12-HETE in concentrations as low as 10`1 M partially restored All action, while concentrations of 10-8 and 10-9 M completely restored the stimulatory effects of All during LO blockade (Fig. 6) . Simi- larly, 12-HPETE (10-8 M) restored the All-mediated aldosterone levels (240±20% basal, All I0-' M alone vs. 95 19%, All + BW755c vs. 210±46%, All + BW755c + 12-HPETE). 12-HPETE also directly stimulated aldosterone secretion (100±5% basal to 133±8%, 10-9 M, n = 6, P < 0.02 and 163±11% 10-8 M, n = 6, P < 0.01 vs. basal). In marked contrast, neither 15-HETE nor 15-HPETE altered aldosterone secretion (100±6% basal vs. 107±11, 15 HETE, 10-8 M and 120±8% 10-8 M, 15-HPETE both P < 0.3, n = 6).
Discussion
Increasing evidence suggests that All in adrenal glomerulosa cells and in isolated vascular smooth muscle activates phospholipase C, resulting in the formation of inositol phosphates and diacylglycerides (4, (22) (23) (24) (8, 11, 25, 26) . Several reports have shown that indomethacin can alter aldosterone synthesis (10, 27, 28) . However, this has not been a consistent finding (8, 11, 25, 26) and the current study as well as others using other more specific CO blockers such as meclofenamate and U-51605 show no inhibition of All induced aldosterone formation (9, 28, 29) . This suggests that indomethacin has nonspecific effects which can alter steroidogenesis.
The current investigation is the first study to show that isolated adrenal glomerulosa cells produce LO products from both endogenous and exogenously derived AA. The major product formed, 12-HETE, was detected using two independent methods, UV detection during HPLC and a specific RIA. The results suggest that 12-LO activation may be a key step in AII-induced aldosterone synthesis. This is supported by several observations including: (a) All, but not (30) . In addition NDGA and ETYA can nonspecifically alter contractile responses independent of effects on LO enzyme inhibition (31) . Also, NDGA at lower doses is a more potent inhibitor of 5-LO activity (32). BW755c did not appear to be toxic based on the normal appearance of the cells, the dose-dependent inhibitory actions on All and its lack of effect on K+ and ACTH-induced aldosterone release. Similarly, BW755c did not appear to be acting as a Ca2' channel blocker since K+ induced aldosterone formation was not altered. This is also supported by the study by Rasmussen and co-workers who showed that BW755c prevented All-induced aldosterone formation without altering All mediated Ca45 flux (26) .
In contrast to the effect of BW755c, phenidone, and baicalein, a specific 5-LO inhibitor U-60257 at doses that have been shown to markedly inhibit 5-LO activation (16) in other cell types, did not prevent AII-induced aldosterone production. These results suggest that the 12 and not the 5-LO pathway is involved in AII-mediated steroidogenesis.
1 5-HETE is also synthesized in the glomerulosa cells in the basal state and in response to All. However, the magnitude of 15-HETE stimulation by All is less than for 12-HETE and neither 15-HPETE nor 15-HETE alter aldosterone synthesis. This suggests that the 1 5-LO pathway is not primarily involved in AII-mediated steroidogenesis. However, additional studies will be required to determine whether 1 5-HETE is involved in other actions of All, such as glomerulosa cell mitogenic activity and growth.
The glomerulosa cell preparation used in the current study may be contaminated with up to 5% fasiculata cells. However, recent evidence suggests that isolated rat fasiculata cells do not synthesize 12-HETE but only the 5-LO derived products such as 5-HETE and LTB4 (33) . In addition, in the rat one would not expect a fasiculata-derived product to be stimulated by All. Therefore, the source of 12-HETE is most likely from 12-HPETE synthesized by the glomerulosa cells.
The mechanism of 12-LO pathway mediated aldosterone synthesis cannot be determined from this study. Since LO blockade diminishes both the aldosterone and corticosterone response to All, the effect appears to modulate the early pathway of aldosterone synthesis. Some evidence suggests that several AA metabolites including the HETEs can activate protein kinase C (34) , while other studies show that 12-HETE can induce vascular smooth muscle migration via changes in Ca2' flux (35) . A very recent study also suggests that AA itself in Ca2, free media can increase intracellular Ca2+ levels in rat islets of Langerhans (36) . Additional studies using specific inhibitors of the protein kinase C and Ca2* messenger systems will be needed to clarify these effects. However, since diacylglycerol is potentially a major source of AA for LO activation, 12-LO products formed most likely function to maintain aldosterone synthesis during the sustained phase of action of All. This is supported by the recent study showing that in a perifusion system BW755c inhibits AII-induced aldosterone synthesis only after 20 min (26) .
Increasing evidence suggests that metabolism ofAA via the LO or cytochrome P-450 epoxygenase pathway may produce important mediators of stimulus-secretion coupling in endocrine tissues such as the pituitary (37) (38) (39) , gonad (40) , and pancreatic islet (12, 13, 41) . The current results now suggest that AA conversion to products of the 12-LO pathway is a key step in All induced action in the adrenal gland. Our results showing no inhibition of 12-HETE with two structurally distinct cytochrome P450 inhibitors suggests that 12-HETE formation in the rat adrenal glomerulosa cell is not via the P450 epoxygenase system described by others in the kidney and liver (42) (43) (44) . However, additional studies will be needed to fully clarify whether other AA metabolites such as epoxides play any role in aldosterone synthesis.
In summary, in isolated glomerulosa cells, AII predominately stimulates the formation of the 12-LO product, 12-HETE, which functions as an important mediator of AII induced aldosterone formation. The synthesis of 12-HETE is specifically linked to AII, since neither K+ or ACTH enhance 12-HETE formation. Since AII is a major regulator of both aldosterone synthesis and vascular smooth muscle tone, these results may form the basis for a new understanding of pathological states in man associated with altered levels or action of angiotensin II.
